Brenner MK - Search Results

1

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.

Gerdemann U, Katari UL, Papadopoulou A, Keirnan JM, Craddock JA, Liu H, Martinez CA, Kennedy-Nasser A, Leung KS, Gottschalk SM, Krance RA, Brenner MK, Rooney CM, Heslop HE, Leen AM. Gerdemann U, et al. Among authors: brenner mk. Mol Ther. 2013 Nov;21(11):2113-21. doi: 10.1038/mt.2013.151. Epub 2013 Jun 20. Mol Ther. 2013. PMID: 23783429 Free PMC article. Clinical Trial.

2

Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study.

Phipps S, Brenner M, Heslop H, Krance R, Jayawardene D, Mulhern R. Phipps S, et al. Bone Marrow Transplant. 1995 Jun;15(6):829-35. Bone Marrow Transplant. 1995. PMID: 7581077

3

Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission.

Brenner M, Krance R, Heslop HE, Santana V, Ihle J, Ribeiro R, Roberts WM, Mahmoud H, Boyett J, Moen RC, et al. Brenner M, et al. Hum Gene Ther. 1994 Apr;5(4):481-99. doi: 10.1089/hum.1994.5.4-481. Hum Gene Ther. 1994. PMID: 8049305 No abstract available.

4

BMT beats autoimmune disease.

Krance R, Brenner M. Krance R, et al. Nat Med. 1998 Feb;4(2):153-5. doi: 10.1038/nm0298-153. Nat Med. 1998. PMID: 9461184 No abstract available.

5

"Resistance is futile".

Brenner M. Brenner M. Gene Ther. 1999 Oct;6(10):1646-7. doi: 10.1038/sj.gt.3301045. Gene Ther. 1999. PMID: 10516712 No abstract available.

6

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Heslop H, et al. Hum Gene Ther. 2000 Jul 1;11(10):1465-75. doi: 10.1089/10430340050057530. Hum Gene Ther. 2000. PMID: 10910143 Clinical Trial. No abstract available.

7

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

Yotnda P, Onishi H, Heslop HE, Shayakhmetov D, Lieber A, Brenner M, Davis A. Yotnda P, et al. Gene Ther. 2001 Jun;8(12):930-7. doi: 10.1038/sj.gt.3301488. Gene Ther. 2001. PMID: 11426333

8

Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells. A model for immunotherapy.

Dotti G, Savoldo B, Takahashi S, Goltsova T, Brown M, Rill D, Rooney C, Brenner M. Dotti G, et al. Exp Hematol. 2001 Aug;29(8):952-61. doi: 10.1016/s0301-472x(01)00668-3. Exp Hematol. 2001. PMID: 11495701 Free article.

9

Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.

Savoldo B, Cubbage ML, Durett AG, Goss J, Huls MH, Liu Z, Teresita L, Gee AP, Ling PD, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. Among authors: brenner mk. J Immunol. 2002 Jan 15;168(2):909-18. doi: 10.4049/jimmunol.168.2.909. J Immunol. 2002. PMID: 11777989

10

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.

Liu Z, Savoldo B, Huls H, Lopez T, Gee A, Wilson J, Brenner MK, Heslop HE, Rooney CM. Liu Z, et al. Among authors: brenner mk. Recent Results Cancer Res. 2002;159:123-33. doi: 10.1007/978-3-642-56352-2_15. Recent Results Cancer Res. 2002. PMID: 11785836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

451 results

Search Page